Is 2024 the year that deals return? After a significant slowdown in M&A for more than a year, a smattering of large deals at the end of 2023 breathed hope of recovery in the market. Will 2024 see a jump in transactions and are IPOs attractive again? Will sellers be forced to accept lower valuations? What sectors and business models are most attractive? How are deals being financed and what is the impact on debt maturity? This mid-year review analyses what has happened so far and predicts what is still to come.

Hedley Goldberg, Partner, Rothschild & Co

How do major investors in the sector view the challenges it faces? How do they view environmental, societal and governance issues? In which sectors and countries do they see opportunities? Are social infrastructure funds with a longer term investment view coming of age? And with the high cost of capital, how do they plan to pay for assets?

Speakers include:

Anastasya Molodykh-McFarlane, Senior Principal, Cinven
Sébastien Veil, Co-Head of Healthcare, PAI Partners

Moderated by: Martin Henrichs, Managing Director, Head of Healthcare EMEA, UBS

How do major investors in the sector view the challenges it faces? How do they view environmental, societal and governance issues? In which sectors and countries do they see opportunities?

Despite optimism in the market and positive macro-economic winds forming, getting deals across the line continues to be a challenge, especially where bid-ask spreads remain wide. This keynote directly follows the Investment banking perspective on the M&A market to give the lawyer’s view, delving into recent deals and analysing the strategies deployed to avoid deals going missing or stalling.

Healthcare needs in emerging markets are considerable and are often not met by existing supply. Investors entering these markets have to be ready for risks, understanding how to spot them early and how to overcome them. This summit developed in partnership with the IFC includes leading investors and healthcare providers operating in emerging markets, sharing their insights, debating key topics and interactive roundtable discussions. 

14.00-14.30: Keynote: Lessons learned from investing in Emerging Markets
Farid Fezoua, Global Director, Health and Education, IFC

For the past 60 years, the IFC has been deploying private capital in emerging and developing markets, at present it has $3.5bn invested in healthcare businesses globally. Right now, emerging markets present an opportunity with huge potential but investors need to proceed with caution. In this opening keynote, Farid lays out the opportunities and gives advice on risks and how to overcome them, reflecting on the lessons the group has learned over the last half-century of investing. 

14.30-15.30: The investor’s viewpoint
Following the opening keynote, a panel of Investors from a broad range of geographies reflect on the topics raised and share their perspectives and lessons learned from their own experience whilst also taking questions from the audience. 
Speakers include: 
Afsane Jetha, Managing Partner and CEO, Alta Semper Capital
Matthew Strassberg, Partner, MidEuropa
Dr Amit Varma, Managing Partner, Quadria Capital
Menka Shah, Partner, IFHA
Moderated by: Silven Chikengezha, Global Sector Lead, Health Services, IFC

15.30-16.15: Networking break

16.15-16.45: The audience’s viewpoint
Having heard the advice and opinions of investors, this interactive discussion is a chance for you, the audience, to share your reactions, debate ideas raised and to prompt further questions. 
Moderated by: Charles Dalton, Global Sector Specialist, Health, IFC.

16.45-17.45: The provider’s viewpoint
Having heard from investors about the opportunities emerging markets offer, here providers tell their stories and what it really takes to achieve growth. Do they agree with the advice investors offer or is their experience different? What is their advice and how can you use that in your own investment strategies?
Speakers include: 
Emmett Moriarty, Managing Director, Ennismore Advisory
Dr Devlina Chakravarty, Managing Director, Artemis Medicare Services
Matt Williams, CEO, Africa Healthcare Network
Moderated by: Raju Narayan, Global Sector Specialist, Health, IFC

17.45-18.00: Closing reflections
Farid Fezoua, Global Director, Health and Education, IFC
Having listened to the perspective of investors, the audience and providers, Farid summaries the key takeaway messages from the afternoon. 
 

Healthcare is a sector that has long stood on the sidelines of environmental sustainability, serving an important social purpose it is already ‘doing its bit’. But serving a social purpose is no longer independent from an environmental purpose, especially when it contributes nearly 5% of the world’s greenhouse gas emissions, twice that of the airline industry.  The challenge for organisations along the entire healthcare value chain is; where do we start?

This interactive workshop developed in partnership with ING is designed for CxOs and investors to come together to understand more about this complex area, share ideas and success stories and start to move the needle on decarbonisation and environmental sustainability. Through a mix of case studies and interactive discussions, attendees will leave with updated strategies, new ideas and an understanding of how to drive change and finance this transformation. 

14.00 – 15.30: Sustainability: making an environmental impact with your organization

The journey of 1,000 miles starts with one step, this well-known saying is a simple concept but challenging in reality. So how should organisations pick their focus areas? How do they measure the impact they are making? How do you set realistic but ambitious medium and long-term targets in areas such as energy efficiency, Co2 emissions, renewable energy, circular economy and waste management? 

This session begins with a case study from an organisation making great progress to draw inspiration before attendees discuss their ideas in small groups.  

15.30-16.00: Networking break

16.00-17.30: The healthcare sector accelerating the transition to a greener economy/ society

 Nothing can entirely be achieved alone, progress requires partnership and each stakeholder to play a role. So how can the entire healthcare value chain collaborate and align on objectives to speed up and scale environmental initiatives? How do we ensure that all parties are reporting on the same framework, what are the barriers and how can they be overcome? What are the quick gains that can be made in scope 3 emissions? 

17.30-18.00 Wrap up: embedding and implementing ESG strategies within the organisation

How do you drive behavioural change and scale initiatives across an organisation? Telling a doctor that they need to follow a new process or change their behaviour isn’t an easy sell. How do business leaders build a culture of purpose where ESG strategies are embraced and adopted and not simply seen as a boardroom directive? How do you finance all of this change, new process and new technology? This session wraps up the key take-aways from the day’s discussion and provides concrete examples of how to build the right culture for change.